Introduction
Background
Introduction
Rheumatoid arthritis (RA) is a chronic multisystemic disease of unknown cause. The characteristic feature is persistent inflammatory synovitis usually involving peripheral joints in a symmetrical distribution. Synovial inflammation causes cartilage destruction and bone erosion. Subsequently, joint deformity occurs. The axial skeleton, with the exception of the cervical spine, is affected later and less frequently.
Lateral view of the cervical spine in a patient with rheumatoid arthritis shows erosion of the odontoid process.
T1-weighted sagittal MRI of the cervical spine shows basilar invagination with cranial migration of an eroded odontoid peg. There is minimal pannus. The tip of the peg indents the medulla, and there is narrowing of the foramen magnum due to the presence of the peg. Inflammatory fusion of several cervical vertebral bodies is shown.
RA activity in the cervical spine begins early, with 83% of patients in prospective studies developing anterior atlantoaxial subluxation within 2 years of disease onset. Activity in the cervical spine progresses clinically and radiologically in tandem with the peripheral-joint involvement. In fact, the severity of the peripheral erosive damage is strongly correlated with the degree of structural damage in the cervical spine. Features of spinal involvement in RA include erosive synovitis, ligamentous subluxation, osteopenia, and vertebral-body fractures.1,2
History
The clinical manifestations were first clearly described in 1800 by Landre-Bouvais, a physician at the Salpetrière Hospital in Paris. It was not until 1859 that Garrod formally named the disease process.3 There is no example of RA in the extensive pathologic collection of William Hunter (1718-1783) at the Royal Infirmary in Glasgow, Scotland.
From a historical perspective, RA appears either to have been absent, relatively rare, or present in a milder form before the 19th century. The era of intensive investigation into the immunologic aspects of RA began following the discovery of rheumatoid factor (RhF) by Waaler in 1940 and by Rose et al in 1948.
Pathophysiology
Histologic and immunologic processes
Microvascular injury and an increase in the number of synovial lining cells appear to be the earliest histologic abnormalities in rheumatoid synovitis. The etiology of these features is unknown. As the disease progresses, the synovium becomes edematous and protrudes into the joint cavity as villous projections.
The synovium in joints expresses an antigen that triggers the production of RhF, an immunoglobulin M directed against autologous immunoglobulin G. This interaction is mediated by polymorphonuclear leukocyte infiltration, complement activation, and immune complex formation and leads to the propagation of a chronic inflammatory response. Lymphokines and other inflammatory mediators initiate an aggressive cascade that culminates in synovial joint destruction with the laying down of pannus.
Rheumatoid pannus describes the granulation tissue that is formed within the synovium by proliferating fibroblasts and inflammatory cells. Mediators of joint destruction include phospholipase A2, prostaglandin E2, and plasminogen activators. Class II molecules are involved in antigen–T-cell interaction.
Genetic predisposition
Studies in families indicate a genetic predisposition. For example, severe RA occurs at approximately 4 times the expected rate in first-degree relatives of individuals with seropositive disease. Approximately 10% of patients with RA have an affected first-degree relative. The role of genetic influences in the etiology of RA was established by the demonstration of an association with HLA-DR4. As many as 70% of patients with classic or definite RA express HLA-DR4 compared with 28% of control subjects.
Frequency
United States
The prevalence of RA is approximately 1% of the adult population in Europe and North America (range, 0.3-2.1%). Some Native American groups have a higher prevalence, with lower rates in the Caribbean. The worldwide incidence is around 3 cases per 10,000 population.
Mortality/Morbidity
Rheumatoid arthritis is usually associated with significant morbidity, disability, and mortality.
- Spontaneous clinical remission is uncommon. After 5 years with the disease, about 33% of patients are unable to work, and after 10 years, around 50% of patients have substantial physical disability.
- Oostveen et al reported an overall mortality rate of 17% in patients with RA and radiographic evidence of cervical subluxation.4 This rate is similar to that found in other series of patients with severe RA and no cervical involvement.
- Poor prognostic factors include persistent synovitis, early erosive disease, extra-articular features, positive serum RhF results, male sex, family history, and advanced age.
Race
Rheumatoid arthritis occurs throughout the world and affects persons of all races. Disease severity differs based on ethnic and geographical variation. For example, studies have shown that RA in Greece is milder, with less radiologic joint destruction and fewer extra-articular manifestations compared with northern European countries.5 The incidence and severity also seem to be lower in rural sub-Saharan Africa than in other areas.
Sex
Women are affected approximately 3 times more often than men. The prevalence increases with age, and sex differences diminish in the older age group.
Age
The onset is more frequent during the fourth and fifth decades of life, with 80% of all patients developing disease from age 35-50 years. The incidence of RA is more than 6 times as great in 60- to 64-year-old women compared with 29-year-old women.
Anatomy
Various phases of joint destruction are seen in rheumatoid arthritis: early RA, erosion formation, pseudocyst formation, and advanced RA.
In early RA, inflammation leads to synovial hyperemia and swelling. Synovial processes adhere to cartilage surfaces at joint periphery.
In the stage of erosion formation, marginal destruction of cartilage, granulation tissue formation, and osteoclastic resorption of nearby bone leads to tissue loss, which is radiologically depicted as erosion.
With pseudocyst formation, granulation tissue formed in continuity with the inflamed synovial membrane continues to replace bone and cartilage at the circumference of articular surfaces. This tissue extends through the surfaces to form radiolucent zones called pseudocysts.
In advanced RA, the extent of synovitis and fasciitis, tendonitis, and cellulitis becomes greater than before. Adhesions between joint surfaces cause ligament and capsule laxity. This, in addition to muscle atrophy and tendonitis, allows joint subluxation to occur. Little normal articular cartilage remains. Secondary osteoarthrosis develops with osteoporosis. Fibrous ankylosis is likely with joint shortening and destruction.
Presentation
Clinical course
There are now believed to be 3 characteristic clinical courses of rheumatoid arthritis: course I, monocyclic; course II, polycyclic; and course III, progressive.6
Course I, monocyclic
Approximately one third of all patients who develop RA undergo complete and permanent remission within 2 years of disease onset, with or without treatment. The course is benign and self-limiting.
Course II, polycyclic
This is a slow, progressive course with moderate activity interspersed with short episodes of acute arthritis. Periods of acute activity become more sustained with the passage of time. This is also known as the palindromic type of RA, and it affects around 40% of patients.
Course III, progressive
This course affects approximately 20% of patients. It represents an unrelenting, progressive, and destructive form of RA with deformity, disfigurement, and even death.
In a given patient, it is not possible to predict the future course of the disease at its outset. However, in the presence of subcutaneous nodules, high titer of RhF, and erosive x-ray changes, rapid progression and destructive changes are inevitable.
Spinal involvement
RA may affect any synovial joint in the vertebral column, but lesions are most commonly seen in the cervical spine. The disease only rarely occurs in the thoracolumbar spine.
Cervical spinal involvement
As early as 1890, Garrod reported that 36% of his patients with RA had cervical-spine involvement. After the metacarpophalangeal joints, the most common region to be involved in RA is the cervical spine. This can lead to severe pain and disability, as well as a variety of neurologic manifestations, although some patients with significant radiographic evidence of disease may be entirely asymptomatic. The frequency of radiographic signs of involvement of the cervical area is in the range of 43-86% depending on the duration of the disease.
Symptoms and signs related to cervical-spinal abnormalities develop in approximately 60-80% of patients with RA at some time during their illness. Pain is the most common clinical manifestation of cervical-spinal involvement, and it may be brief or sustained in duration. Weakness and abnormal mobility can also be evident. Neurologic manifestations occur in 11-58% of patients with RA and include paresthesias, paresis, muscle wasting, quadriplegia, and even sudden death. This finding is well correlated with elevated levels of C-reactive protein, peripheral joint involvement, and carpal collapse.
A number of RA disease- and patient-related factors may contribute to the development of cervical spine involvement. These include the following:
- Severe polyarthritis is common in patients with cervical spine involvement, most of whom also have rheumatoid nodules. Often, coexisting severe erosive destruction is present in the hands and feet and at the hips and knees.
- Patients with immunoglobulin M rheumatoid factor are at higher risk for cervical spine involvement. Moreover, seronegative disease is less severe.
- The C-reactive protein concentration at the onset of RA may predict the subsequent development of cervical spine involvement.
- Older patients are more likely to have lesions in the lower spine.
- Degenerative disk disease may contribute to the severity of cervical spine involvement and to the development of dislocation.
- The effect of disease duration on cervical spine changes is controversial. Cervical spine involvement has been described within 2 years of disease onset. In a 5-year study by Pellicci et al in 106 RA patients, radiological evidence of cervical spine involvement was present in 43% of patients at baseline and in 76% of patients at last follow-up.7
- The role of long-term steroid therapy is somewhat controversial. One study suggests that this may contribute to promoting cervical spine damage by virtue of alleviating the pain that might otherwise limit neck movements. Corticosteroids are well known to induce osteoporosis, and this may decrease the mechanical strength of the cervical spine, although this theory has been challenged. In a study by Rudge et al, corticosteroid treatment was associated with an increased incidence of SAS.8 This was related to duration of treatment. Recent studies with the newer DMARDs have suggested that early and aggressive treatment may prevent or retard the development of cervical spine changes.9,10
Pathoanatomy of cervical spinal involvement
The entire cervical spine is involved in the rheumatoid process. Changes may be evident as far cephalad as the base of the occiput and as far caudad as the cervicothoracic junction. More specifically, synovial and cartilaginous articulations, the joints of Luschka, tendinous and ligamentous attachments, and soft tissues of the cervical region can develop significant abnormalities.
Atlantoaxial subluxation (AAS) is the result of erosive rheumatoid synovitis in the atlantoaxial, atlanto-odontoid and atlanto-occipital joints and in the synovium-lined bursa between the anterior arch of C1, the odontoid process, and the transverse ligament. Subluxation is normally prevented by the action of several ligaments, especially the transverse ligament, which connects the lateral masses of the atlas and maintains the normal position of the odontoid process. The alar ligaments and, to a lesser extent, the apical ligaments also play a critical role in stability of this region.
Synovitis within the articulations of the cervical spine causes destruction of the articular cartilage with direct extension of rheumatoid pannus into the spinal canal. Simultaneous involvement of ligaments causes laxity and rupture, promoting instability and subluxation. These factors in combination produce compression of the spinal cord or nerve roots, and may even compress the vertebral arteries. Progressive disease can also trigger off a cascade of events causing significant bone destruction, osteoporosis, instability, and fractures of the vertebral bodies or the posterior neural arches.
Subluxation
The synovial inflammatory process within the 4 atlantoaxial articulations often results in subluxation, of which 4 major types are recognized. The anterior type of subluxation is the most common and is present in 65% of RA patients undergoing total joint replacement, although only 50% of these are symptomatic. Results of physical examination may be misleading in its assessment because of a myriad of physical signs from tendon rupture, tenosynovitis, peripheral neuropathy, and myelopathy. It is typified by abnormal separation between the anterior arch of the atlas and the odontoid process of the axis. Generally, the interosseous distance between the posterior aspect of the anterior arch of the atlas and the anterior aspect of the odontoid process should not exceed 2.5 mm in adults.
The atlantoaxial subluxation can also occur in a posterior direction; this is seen in around 7% of all rheumatoid subluxations, but it is not usually associated with spinal cord compromise. Lateral subluxation is defined as offset of the lateral masses of the atlas in relation to the axis of greater than 2 mm, and it is usually associated with a rotational deformity. An irreducible head tilt is also seen in 10% of cases.
Vertical subluxation (VS) accounts for 22% of all other subluxations, and when extensive can be fatal. It is also known as cranial settling or atlantoaxial impaction and results from the combined bone and cartilage loss in the atlantoaxial and atlanto-occipital articulations. It may coexist with the more common anterior AAS.
Rheumatoid involvement of the subaxial cervical spine is most often seen at the C3-4 and C4-5 levels where the facet joints and interspinous ligaments are involved along with the intervertebral disks. The C7-T1 level is also a common site for subluxation and radiographs of the cervical spine must include this area. Multilevel subluxations produce the characteristic stepladder configuration, which is found in 10-20% of patients. In most cases, subluxations are not fixed in the abnormal position. Rather, changes in alignment can be demonstrated on lateral radiographs taken during flexion and extension of the neck.
Changes of the spinal canal are seen as a direct consequence of the subluxations highlighted primarily by pachymeningitis, arachnoiditis, cord ischemia and CSF and cord compression. Neurologic compression is more common in the subaxial portion of the cervical spine, where the spinal canal is less capacious, than elsewhere. It may especially occur below the level of a cervical fusion and in the presence of anterior spondylodiskitis, intracanal-rheumatoid granulations, and a hyperlordotic configuration. When cervical myelopathy is present, mortality is a common outcome if untreated, but in 10% of cases, sudden death can occur owing to fatal high-cervical medullary compression.11,12
Thoracic and lumbar spinal involvement
Abnormalities of the thoracic and lumbar spine are relatively rare in this disease. Destructive lesions of the vertebral bodies that may histologically resemble rheumatoid nodules have been occasionally described. These granulomatous foci involve the vertebral body and may extend to the vertebral endplates and allow collapse of subchondral bone and intervertebral disk abnormalities. Rare cases of extradural rheumatoid nodules producing spinal cord compression have been described.
RA changes in the apophyseal joints of the thoracic and lumbar spine are reported only infrequently. Alterations at the discovertebral junctions have also been noted. Intervertebral disk-space narrowing, irregularity of the subchondral margins of the vertebral bodies, erosion and sclerosis can be evident on radiography. Patients with RA who are receiving corticosteroid medication are predisposed to ischemic necrosis of bone. Although the femoral head is the usual site for this, vertebral bodies in the thoracic and lumbar regions of the spine can be affected. On radiography, this may be seen as vertebral collapse and fragmentation. Radiolucent fracture lines, which may accumulate gas from surrounding tissues, are an important clue to the diagnosis.
Patient Education: For excellent patient education resources, visit eMedicine's Arthritis Center.
Differential Diagnoses
Ankylosing Spondylitis
Juvenile Rheumatoid Arthritis
Spondylodiskitis
More on Rheumatoid Arthritis, Spine |
Overview: Rheumatoid Arthritis, Spine |
| Imaging: Rheumatoid Arthritis, Spine |
| Follow-up: Rheumatoid Arthritis, Spine |
| Multimedia: Rheumatoid Arthritis, Spine |
| References |
| Further Reading |
| Next Page » |
References
Cassar-Pullicino VN. The Spine in Rheumatological Disorders. Imaging. Vol 11. 1999: 104-18.
Resnick D, Kyriakos M, Greenway GD. Rheumatoid arthritis. In: Diagnosis of Bone and Joint Disorders. Vol 2. 4th ed. Philadelphia: WB Saunders;. 2002: 891-974.
Garrod AB. Nature and treatment of gout and rheumatic gout. London: Walton and Maberly;. 1859.
Oostveen JC, Roozeboom AR, van de Laar MA, Heeres J, den Boer JA, Lindeboom SF. Functional turbo spin echo magnetic resonance imaging versus tomography for evaluating cervical spine involvement in rheumatoid arthritis. Spine. Jun 1 1998;23(11):1237-44. [Medline].
Drosos AA, Lanchbury JS, Panayi GS, Moutsopoulos HM. Rheumatoid arthritis in Greek and British patients. A comparative clinical, radiologic, and serologic study. Arthritis Rheum. Jul 1992;35(7):745-8. [Medline].
Papadopoulos IA, Katsimbri P, Katsaraki A, et al. Clinical course and outcome of early rheumatoid arthritis. Rheumatol Int. Jul 2001;20(5):205-10. [Medline].
Pellicci PM, Ranawat CS, Tsairis P, Bryan WJ. A prospective study of the progression of rheumatoid arthritis of the cervical spine. J Bone Joint Surg Am. Mar 1981;63(3):342-50. [Medline].
Rudge SR, Drury PL, Lloyd-Jones JK. Long-term corticosteroids and cervical subluxation in non-rheumatoid patients. Rheumatol Rehabil. May 1981;20(2):102-5. [Medline].
Neva MH, Kauppi MJ, Kautiainen H, et al. Combination drug therapy retards the development of rheumatoid atlantoaxial subluxations. Arthritis Rheum. Nov 2000;43(11):2397-401. [Medline].
Kauppi MJ, Neva MH, Laiho K, Kautiainen H, Luukkainen R, Karjalainen A, et al. Rheumatoid Atlantoaxial Subluxation Can Be Prevented by Intensive Use of Traditional Disease Modifying Antirheumatic Drugs. J Rheumatol. Feb 2009;36(2):273-278. [Medline].
Hamilton JD, Johnston RA, Madhok R, Capell HA. Factors predictive of subsequent deterioration in rheumatoid cervical myelopathy. Rheumatology (Oxford). Jul 2001;40(7):811-5. [Medline].
Paus AC, Steen H, Røislien J, Mowinckel P, Teigland J. High mortality rate in rheumatoid arthritis with subluxation of the cervical spine: a cohort study of operated and nonoperated patients. Spine. Oct 1 2008;33(21):2278-83. [Medline].
Boden SD, Dodge LD, Bohlman HH, Rechtine GR. Rheumatoid arthritis of the cervical spine. A long-term analysis with predictors of paralysis and recovery. J Bone Joint Surg Am. Sep 1993;75(9):1282-97. [Medline].
McGregor M. The significance of certain measurments of the skull in the diagnosis of basilar impression. Br J Radiol. 1948;21:171-81.
Kelleher MO, McEvoy L, Yang JP, Kamel MH, Bolger C. Lateral mass screw fixation of complex spine cases: a prospective clinical study. Br J Neurosurg. Oct 2008;22(5):663-8. [Medline].
Cakir B, Käfer W, Reichel H, Schmidt R. [Surgery of the cervical spine in rheumatoid arthritis. Diagnostics and indication]. Orthopade. Nov 2008;37(11):1127-40; quiz 1141. [Medline].
Narváez JA, Narváez J, Serrallonga M, De Lama E, de Albert M, Mast R, et al. Cervical spine involvement in rheumatoid arthritis: correlation between neurological manifestations and magnetic resonance imaging findings. Rheumatology (Oxford). Dec 2008;47(12):1814-9. [Medline].
Dvorak J, Grob D, Baumgartner H, et al. Functional evaluation of the spinal cord by magnetic resonance imaging in patients with rheumatoid arthritis and instability of upper cervical spine. Spine. Oct 1989;14(10):1057-64. [Medline].
Janssen H, Weissman BN, Aliabadi P, Zamani AA. MR imaging of arthritides of the cervical spine. Magn Reson Imaging Clin N Am. Aug 2000;8(3):491-512. [Medline].
Roche CJ, Eyes BE, Whitehouse GH. The rheumatoid cervical spine: signs of instability on plain cervicalradiographs. Clin Radiol. Apr 2002;57(4):241-9. [Medline].
Roca A, Bernreuter WK, Alarcón GS. Functional magnetic resonance imaging should be included in the evaluation the cervical spine in patients with rheumatoid arthritis. J Rheumatol. Sep 1993;20(9):1485-8. [Medline].
Weissman BN, Aliabadi P, Weinfeld MS, et al. Prognostic features of atlantoaxial subluxation in rheumatoid arthritispatients. Radiology. Sep 1982;144(4):745-51. [Medline].
Mertens M, Singh JA. Anakinra for rheumatoid arthritis. Cochrane Database Syst Rev. Jan 21 2009;CD005121. [Medline].
Salliot C, Dougados M, Gossec L. Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials. Ann Rheum Dis. Jan 2009;68(1):25-32. [Medline].
Hagen KB, Byfuglien MG, Falzon L, Olsen SU, Smedslund G. Dietary interventions for rheumatoid arthritis. Cochrane Database Syst Rev. Jan 21 2009;CD006400. [Medline].
Further Reading
Related eMedicine topics
Rheumatoid Arthritis
Rheumatoid Arthritis, Hands
Juvenile Rheumatoid Arthritis
Clinical guidelines
Ophthalmologic examinations in children with juvenile rheumatoid arthritis. American Academy of Pediatrics. 2006 May 1. 3 pages. NGC:004963
Ottawa Panel evidence-based clinical practice guidelines for therapeutic exercises in the management of rheumatoid arthritis in adults. Ottawa Panel - Independent Expert Panel. 2004 Oct. 39 pages. NGC:004019
Ottawa Panel evidence-based clinical practice guidelines for electrotherapy and thermotherapy interventions in the management of rheumatoid arthritis in adults. Ottawa Panel - Independent Expert Panel. 2004 Nov. 28 pages. NGC:004020
Rituximab for the treatment of rheumatoid arthritis. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2007 Aug. 26 pages. NGC:005902
Abatacept for the treatment of rheumatoid arthritis. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2008 Apr. 29 pages. NGC:006483
Clinical trials
RESTART C0168Z05 Rheumatoid Arthritis Study
Evaluation of EULAR-RAID Score in Rheumatoid Arthritis Patients
Clinically Important Changes in Rheumatoid Arthritis
Ultrasonography as a Biomarker in Early Rheumatoid Arthritis
Health Outcomes in Rheumatoid Arthritis
Long-Term Evaluation of African Americans With Early Rheumatoid Arthritis (The CLEAR Study)
Keywords
spinal arthritis, spinal rheumatoid arthritis, spinal RA, early RA, early rheumatoid arthritis, erosion formation, pseudocyst formation, advanced RA, advanced rheumatoid arthritis, rheumatoid factor, RhF, course I rheumatoid arthritis, monocyclic rheumatoid arthritis, course II rheumatoid arthritis, polycyclic rheumatoid arthritis, course III rheumatoid arthritis, progressive rheumatoid arthritis, rheumatoid spondylitis, rheumatoid arthritis




Overview: Rheumatoid Arthritis, Spine